tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RYTM Stock Latest News

Rhythm Pharmaceuticals Announces New Employment Inducement Grants
Press ReleasesRhythm Pharmaceuticals Announces New Employment Inducement Grants
11d ago
RYTM
Rhythm Pharmaceuticals appoints Garfield as Chief Scientific Officer
PremiumThe Fly
Rhythm Pharmaceuticals appoints Garfield as Chief Scientific Officer
14d ago
RYTM
Rhythm Pharmaceuticals Receives Positive CHMP Opinion for ▼IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients between 2 and 6 years old with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency
PremiumPress Releases
Rhythm Pharmaceuticals Receives Positive CHMP Opinion for ▼IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients between 2 and 6 years old with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency
24d ago
RYTM
Rhythm Pharmaceuticals receives positive CHMP opinion for IMCIVREE
PremiumThe Fly
Rhythm Pharmaceuticals receives positive CHMP opinion for IMCIVREE
24d ago
RYTM
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
PremiumPress Releases
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
1M ago
RYTM
Rhythm: Patient-reported experiences with hyperphagia in HO presented at ENDO
PremiumThe FlyRhythm: Patient-reported experiences with hyperphagia in HO presented at ENDO
2M ago
RYTM
Rhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024
PremiumPress Releases
Rhythm Pharmaceuticals Presents Patient-reported Experiences with Hyperphagia in Hypothalamic Obesity at ENDO 2024
2M ago
RYTM
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
PremiumPress Releases
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
2M ago
RYTM
Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome
PremiumPress Releases
Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome
2M ago
RYTM
Rhythm Pharmaceuticals price target lowered to $79 from $80 at Canaccord
PremiumThe Fly
Rhythm Pharmaceuticals price target lowered to $79 from $80 at Canaccord
3M ago
RYTM
Rhythm Pharmaceuticals downgraded at BofA on less steep uptake for Imcivree
PremiumThe Fly
Rhythm Pharmaceuticals downgraded at BofA on less steep uptake for Imcivree
3M ago
RYTM
Rhythm Pharmaceuticals downgraded to Neutral from Buy at BofA
PremiumThe Fly
Rhythm Pharmaceuticals downgraded to Neutral from Buy at BofA
3M ago
RYTM
Rhythm Pharmaceuticals announces anticipated upcoming milestones
PremiumThe FlyRhythm Pharmaceuticals announces anticipated upcoming milestones
3M ago
RYTM
Rhythm Pharmaceuticals reports Q1 EPS ($2.35) , consensus ($2.16)
PremiumThe Fly
Rhythm Pharmaceuticals reports Q1 EPS ($2.35) , consensus ($2.16)
3M ago
RYTM
Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update
PremiumPress Releases
Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update
3M ago
RYTM
Rhythm Pharmaceuticals presents data from Phase 3 pediatrics trial
PremiumThe Fly
Rhythm Pharmaceuticals presents data from Phase 3 pediatrics trial
3M ago
RYTM
Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology
PremiumPress Releases
Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology
3M ago
RYTM
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
PremiumPress Releases
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
3M ago
RYTM
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
PremiumPress Releases
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
3M ago
RYTM
Rhythm Pharmaceuticals secures $150M in convertible preferred stock financing
PremiumThe FlyRhythm Pharmaceuticals secures $150M in convertible preferred stock financing
4M ago
RYTM
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
PremiumPress Releases
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
4M ago
RYTM
Rhythm announces first patient dosed in Phase 1 trial of RM-718
PremiumThe Fly
Rhythm announces first patient dosed in Phase 1 trial of RM-718
4M ago
RYTM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >